Nova Nutria AG
ImunoLogic® – New revolutionary product strengthening the immune system
Nova Nutria AG / Product Launch Release of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer / publisher is solely responsible for the content of this announcement. ---------------------------------------------------------------------- Burgau, 20.11.2008 Nova Nutria® International AG introduces a new food product for particular nutritional uses and special medical needs (balanced diet) for dietary treatment of diseases which are associated with immunological disturbances and immune weaknesses, particularly with regard to cancer, infections and certain allergies, which is registered with the German Federal Office of Consumer Protection and Food Safety (BVL). After 3-years of research and development now is the right time to launch the product for worldwide commercialization under the trade name ImunoLogic®. A central active principle of the product is the modulation of the cellular and humoral immunity (TH2-TH1-Immuno-Shift) with spices and botanical extracts based on specially developed carriers. The deployed technologies MNCS-IMS™ and MNCS-GLS™ are based on modern findings of the quantum chemistry and also natural developed nano carriers. Within the scope of a scientific study, the increase in immune response could be doubtless observed and recorded with test people who used the product with the special spices over the period of many months. The immune response, measured by the amount of body T-Helpercells type CD4+, could be multiplied by ten after a period of 90 days. In a study with 40 AIDS patients in an advanced state (male and female between the ages of 19 and 48 years) the influence of the viral load and the general physical health were examined amongst other things. After 90 days, 28 patients (74 % of 38) were not anymore in the area of AIDS in an advanced state. The average viral load reduces from 500000 (copies / ml PCR) to 330. In all cases diarrhoea ceased and the body weight normalized. Six months after the start of the study 19 AIDS-patients were able to work full-time again. The patent application for this product has been agreed upon and commissioned by the board of managers from the Nova Nutria® International AG. At a time, with ever increasing infectional risks, environmental problems and foodstuff scandals, the allocation of resistance building substances is sorely needed. A weak immune system cannot effectively fight illness. The Nova Nutria® AG, sales department, Jörg D. Wittke, estimates the market prospects and distribution possibilities for ImmunoLogic® across Europe at several hundred million Euros. The Nova Nutria® Group is a Europe-wide active business with product development based on its own research and has dedicated itself to the subject of Bio-Signalling-Nutrition. The group of companies belongs today to the leading companies in research, development and production of products based on the Bio-Signal-Theory. Thereby the focus lays on the research, production and the sale of high quality dietary supplements for man and beast, dietary foodstuffs, functional cosmetics, as well as home and personal care products. The Nova Nutria® AG is listed on the Frankfurt Stock Exchange under the stock symbol 47N. The Nova Nutria® International AG, responsible for the central sales service and the Europe-wide logistic was founded in 2002 and has its head office in Burgau (Germany). Sebastian Eisele - Assistant of the management Nova Nutria® International AG Schmiedberg 13 | 89331 Burgau T +49 (0) 8222 414 900 | F +49 (0) 8222 414 90 - 10 s.eisele@novanutria.de | www.novanutria.de 20.11.2008 Financial News transmitted by DGAP ----------------------------------------------------------------------
Latest News
Latest Reports
No Reports found
Upcoming Events
No Events found
Webcasts
No Webcasts found